MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: Strategic Corporate Investment & Corporate Venture Capital (CVC)
Portfolio Companies: GSK:SR One Ltd (#6 Medical Strategic Investment)
Aileron Therapeutics, Inc. (NASDAQ: ALRN)*
Organization & Developments: Aileron
Parents
Aileron Therapeutics, Inc. (NASDAQ: ALRN)*
Children
2010: Aileron and Scripps Ink Deal (2010)
2021: Aileron Therapeutics: An Assessment On A Lottery Ticket
2021: Aileron Therapeutics: Low Cash Balance, Early Stage, But Scientific Premise Is Interesting
2021: Our First Look At Aileron Therapeutics
Aileron is developing the first generation of peptide therapeutics directed at intra-cellular protein-protein interaction target
Biopharmaceutical company that is applying its proprietary cell permeable peptide technology to generate breakthrough therapeuti
First and only process that allows peptides to penetrate cells in a sequence-independent manner.
Jumps
Finance & Acquisitions: Aileron
Key People: Aileron